sciencenewsnet.in

The Medical Minute: Getting to the heart of heartburn─what to know, how to treat it

November 6, 2024 sarah JonasFeature

One in five Americans suffers from acid reflux or gastroesophageal reflux disease, when stomach acid flows back into the esophagus. Treatments include lifestyle changes, medications and now a minimally invasive procedure called the LINX Reflux Management System.

Use of Acid Reflux Drugs Linked to Higher Risk of Migraine

April 24, 2024 sarah JonasResearch Results

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology® Clinical Practice, an official journal of the American Academy of Neurology. The acid-reducing drugs include proton pump inhibitors such as omeprazole and esomeprazole, histamine H2-receptor antagonists, or H2 blockers, such as cimetidine and famotidine, and antacid supplements.

Long-Term Use of Certain Acid Reflux Drugs Linked to Higher Risk of Dementia

August 9, 2023 sarah JonasResearch Results

People who take acid reflux medications called proton pump inhibitors for four-and-a-half years or more may have a higher risk of dementia compared to people who do not take these medications, according to new research published in the August 9, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. This study does not prove that acid reflux drugs cause dementia; it only shows an association.

Acid Reflux in People with Barrett’s Esophagus May Change Cells to Cause Cancer

June 3, 2022 sarah JonasResearch Alert

Article title: A human Barrett’s esophagus organoid system reveals epithelial-mesenchymal plasticity induced by acid and bile salts Authors: Qiuyang Zhang, Ajay Bansal, Kerry B. Dunbar, Yan Chang, Jianning Zhang, Uthra Balaji, Jinghua Gu, Xi Zhang, Eitan Podgaetz, Zui Pan, Stuart…

Tips for enjoying your holiday meal while managing GERD

November 25, 2019 sarah JonasFeature

Experts from the University of Chicago Medicine Center for Esophageal Diseases share their tips on how to celebrate Thanksgiving without feeling the sting of acid reflux.

New Research Could Change Clinical Practice for Cases of Unmanaged Heartburn

October 17, 2019 sarah JonasResearch Results

A study published today in The New England Journal of Medicine found that in patients seen for heartburn unresponsive to treatment with Proton Pump Inhibitors (PPIs), an extensive, systematic workup revealed truly PPI-refractory and reflux-related heartburn in only a minority of cases. In other words, most patients with heartburn unrelieved by PPIs did not have gastroesophageal reflux disease (GERD) causing the symptom. Furthermore, for the selected subgroup identified as having reflux-related, PPI-refractory heartburn, surgery that corrects reflux was significantly superior (67% success rate) to continued medical therapy (28% success rate).